Funding Opportunities for External Collaborative Research (ECR)
External Collaborative Research (ECR)
The Boehringer lngelheim ECR Program is offered to academic and clinical scientists, who are interested in proposing a research study and wish to collaborate with Boehringer lngelheim - as the supportive partner - to further develop a protocol and analyze and/or publish the results. In addition to providing intellectual contributions, Boehringer lngelheim may provide drug and/or financial support to an approved ECR.
The collaborative partner must assume all responsibility (including under applicable regulations) and retain ultimate control over the conduct of the ECR including acting as a regulatory sponsor.
Boehringer lngelheim does not serve as the regulatory sponsor for ECR.
The budget for such studies should reflect the funding required to conduct the research (e.g. actual costs of materials and services) and cannot include direct salary support of the collaborative partner.
Boehringer lngelheim requires investigators to apply for support via an online application process.
GENERAL FAQs
FAQs
Expand AllYes. Boehringer Ingelheim requires applications to be submitted via an online grant portal, Boehringer Ingelheim Funding Portal.
Clinical Research Grant applications are offered to all qualified academic and community based scientists or consortia who are interested in independently proposing and conducting their own research.
Grant proposals for Investigator Initiated Studies (IIS) and External Collaborative Research (ECR) are accepted.
For Investigator Initiated Studies (IIS), a Sponsor-Investigator independently proposes and conducts the research. Boehringer Ingelheim does not provide feedback on the study proposal or operational support for research conduct. For External Collaborative Research (ECR), a Sponsor-Investigator and Boehringer Ingelheim work collaboratively on the research proposal. However, regulatory responsibility lies solely with the sponsor institution. A detailed differentiation of grants types can be found in the overview table "What is the difference between IIS and ECR?".
The same process applies for proposals that request drug only, financial only, or both drug and funding.
A synopsis is an abbreviated application used to gauge Boehringer Ingelheim’s interest in the research study. A Full Proposal contains detailed information about the budget and requires a Feasibility Check Form as well as a signed Curriculum Vitae. Ultimately, funding/drug support decisions can only be made upon Boehringer Ingelheim’s review of a full proposal.
The review committee evaluates submissions of synopses and full proposals on a rolling basis and according to their scientific merit, alignment with our areas of interest, and available funding. Boehringer Ingelheim will issue a decision, either approval or denial, to the Sponsor-Investigator using the contact information provided in the grant submission.
If your application is approved, a contract, including budget with payment milestones, is executed between the institution of the Sponsor-Investigator and Boehringer Ingelheim. Financial and/or drug support is contingent upon full execution of the contract by both parties. Other study activities, e.g. Protocol, Study Management, etc. are to be managed with the online grant portal (execution panel) and should be updated as needed.
Contract execution can vary widely depending on the complexity of the negotiations and the requirements of Boehringer Ingelheim and the sponsor institution. Please consider this when planning timelines of your study.
Yes, you may submit additional proposals, however, please note that any non-compliance in the ongoing study may preclude the review of new submissions until any issues are resolved.
Yes, we welcome the submission of other novel study ideas.
TECHNICAL FAQs
FAQs
Expand AllFor the best experience, we suggest using the latest version of Chrome, Firefox, Edge or Safari. Some features may not be available in IE11.
Click on the “Forgot Password” link under the password field on the landing page to reset your password. A new password will be sent to your registered email.
Your user profile can be updated by clicking “My Profile” in the top right-hand corner where you find your initials. Please update your profile if your email or contact information has changed so that we can continue to communicate with you about the application.
If no activity occurs within the portal for 90 minutes, your session will time out and any unsaved data will be lost. We recommend you to save your application regularly by clicking on the Save Draft button.
You are able to save your work and come back to it another time by clicking “Save Draft” at the bottom of the page. At any time prior to submitting, you will be able to make changes to the application. However, once you click “Submit Application”, your application will be locked from editing.
Send any additional/updated documents via email using the assistance link that is up in your application. Please make sure to include the Grant-ID in the subject line of the email.
Go to the “Boehringer Ingelheim Funding Portal” home screen and scroll to the bottom of the page to “Applications in Progress”. The status is displayed there.
Yes, you may invite Co-Applicants using the “Invitation” link on toolbar on the left side in your application. Alternatively, scroll down to the bottom of your application to invite additional Co-Applicants using the available field.
Email notifications will be sent to the registered user account throughout the process. In addition, your responsible Boehringer Ingelheim Medical Affairs Coordinator will be in close contact with you for the entire duration of the study. You also have the possibility to log onto “Boehringer Ingelheim Funding Portal” at any time to manage your proposals, view the status of your requests directly, and view any pending action items.